Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy. [electronic resource]
Producer: 20000630Description: 187-93 p. digitalISSN:- 1368-4736
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Small Cell -- drug therapy
- Cyclophosphamide -- adverse effects
- Doxorubicin -- adverse effects
- Etoposide -- adverse effects
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mouth Mucosa -- drug effects
- Necrosis
- Neutropenia -- chemically induced
- Proportional Hazards Models
- Prospective Studies
- Recombinant Proteins
- Stomatitis -- chemically induced
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.